Articles tagged with Nk Cell Receptor Signaling
Adaptive NK cells exhibit tumor-specific immune memory and cytotoxicity in ovarian cancer, making them promising for cancer treatment. The study challenges previous perceptions of NK cells, which have historically been considered only innate immune cells with no memory function against cancer.
Researchers from the University of Cincinnati Cancer Center presented abstracts highlighting contrasting effects of a protein on head and neck, breast, and lung cancers. The study found increased levels of IL-9 in patients with head and neck cancer correlated with decreased survival, while elevated IL-9 was associated with smaller tumo...
Scientists at Goethe University Frankfurt have discovered a new way to tailor natural killer cells to target leukemia cells, improving their efficacy. The researchers used CRISPR/Cas9 gene editing to disable an immune checkpoint, allowing the modified cells to attack cancer cells more effectively.
Researchers at University of California San Diego have found that genetically modified NK-cell therapy can effectively target and treat hepatocellular carcinoma, a highly treatment-resistant form of solid tumor. The therapy works by disabling the inhibitory protein TGF-β, allowing immune cells to kill cancer more efficiently.
A team of researchers from Texas Heart Institute and Baylor College of Medicine have made a significant discovery about the underlying molecular cell states within transplanted pediatric hearts. They found that donor-derived tissue-resident macrophages are crucial for graft acceptance, but their loss leads to allograft failure.
A new CAR NK cell engineering approach requires two signals to eliminate target cells, improving tumor specificity and enhancing anti-tumor activity. This strategy mitigates NK cell exhaustion and fratricide, leading to better focus on and attack of only the tumor cells.
Researchers identified specific genetic signals in people with severe coronavirus infection using machine learning. They found that more than 1,000 genes linked to the development of severe COVID-19 cases account for three-quarters of the genetic drivers for severe illness.
Research reveals distinct cellular receptor mutations influence COVID-19 disease severity, with high-affinity variants associated with increased risk. The study found that these genetic variants lead to an exaggerated immune response and enhanced antibody-dependent activation of killer cells.
A new study by Karolinska Institutet reveals that natural killer cells respond to a specific peptide on the surface of infected cells. This peptide triggers an activation response in NK cells carrying the NKG2A receptor, allowing them to kill virus-infected cells.
Researchers used high-speed microscopy to observe NK cell behavior when interacting with healthy or diseased cells, discovering that the cell's surface receptors determine whether it kills or leaves a cell alone. Understanding this process could lead to new ways of boosting immune defenses to treat disease.
Researchers found a genetic connection between preeclampsia and the interaction between trophoblast cells and natural killer cells. The study suggests that a specific protein combination may be responsible for suppressing the NK cells' ability to stimulate vessel remodeling, leading to decreased blood flow to the fetus.